Current Neuropharmacology
Title:Editorial: The Role of Ca2+-activated K+ Channels of Intermediate Conductance in Glioblastoma Malignancy
Volume: 16 Issue: 5
Author(s): Luigi Catacuzzeno and Fabio Franciolini
Affiliation:
Export Options
About this article
Cite this article as:
Catacuzzeno Luigi and Franciolini Fabio , Editorial: The Role of Ca2+-activated K+ Channels of Intermediate Conductance in Glioblastoma Malignancy, Current Neuropharmacology 2018; 16 (5) . https://dx.doi.org/10.2174/1570159X1605180510154222
DOI https://dx.doi.org/10.2174/1570159X1605180510154222 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
29
3
1
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Computational Methods and Algorithms for Mass-Spectrometry Based Differential Proteomics
Current Proteomics The Neuropeptide Systems and their Potential Role in the Treatment of Mammalian Retinal Ischemia: A Developing Story
Current Neuropharmacology Boundaries and Overlap between Hypochondriasis and Other Disorders: Differential Diagnosis and Patterns of Co-occurrence
Current Psychiatry Reviews Radiometal Complexes in Molecular Imaging and Therapy
Current Medicinal Chemistry The Association between Depression and Gastroesophageal Reflux based on Phylogenetic Analysis of miRNA Biomarkers
Current Medicinal Chemistry Experimental Model Considerations for the Study of Protein-Energy Malnutrition Co-Existing with Ischemic Brain Injury
Current Neurovascular Research Does Ceruloplasmin Defend Against Neurodegenerative Diseases?
Current Neuropharmacology Effectors of Fatty Acid Oxidation Reduction: Promising New Anti-Ischaemic Agents
Current Pharmaceutical Design Therapeutic Opportunities for Trophic Factors in Brain Inflammation
Current Pharmaceutical Analysis Targeting Ras-RAF-ERK and its Interactive Pathways as a Novel Therapy for Malignant Gliomas
Current Cancer Drug Targets Leukocyte Influx in Atherosclerosis
Current Drug Targets Maternal Sepsis 2010: Early Recognition and Aggressive Treatment with Early Goal Directed Therapy can Improve Maternal Outcomes
Current Women`s Health Reviews Neonatal Fever in the Term Infant: Evaluation and Management Strategies
Current Pediatric Reviews Insulin Resistance and Alzheimers Disease: Molecular Links & Clinical Implications
Current Alzheimer Research IL-3 Control Tau Modifications and Protects Cortical Neurons from Neurodegeneration
Current Alzheimer Research Novel Nanotechnology Approaches for Targeted Cancer Therapy
Recent Patents on Nanomedicine Potential Effects of Cannabidiol as a Wake-Promoting Agent
Current Neuropharmacology Mesenchymal Stem Cell Therapy in Intracerebral Haemorrhagic Stroke
Current Medicinal Chemistry Biomarkers of Cell Damage Induced by Oxidative Stress in Parkinsons Disease and Related Models
Central Nervous System Agents in Medicinal Chemistry Clinical and Pre-clinical Applications of the Transcendental Meditation Program® in the Prevention and Treatment of Essential Hypertension and Cardiovascular Disease in Youth and Adults
Current Hypertension Reviews